The ARV Therapies and Therapeutic Strategies program is a comprehensive, independent review of IDWeek 2020. This program consists of two components: (1) From Conference to Clinic: Reviewing and Applying Data from IDWeek 2020: a case-based on-line webcast featuring expert faculty reviewing key presentations with a focus on clinical management and treatment; and (2) IDWeek 2020 e-Newsletter:** a brief on-line summary of the most essential data presented at the conference.
The CME Internet Symposium: From Conference to Clinic: Reviewing and Applying Data from IDWeek 2020 will feature a panel of HIV experts reviewing key presentations on antiretroviral therapy presented at IDWeek 2020. The review will include several clinical cases focusing on HIV therapeutic options and developments, including: current treatment and management strategies; algorithms and recommendations; therapies in development; epidemiology, diagnosis and clinical management of specific patient populations. This activity will enable participating health care providers caring for HIV-infected patients to become aware of and understand the data presented at this important conference and appropriately utilize those data to improve patient care. All on-line components of the program can be accessed at www.viraled.com.
This program is jointly provided by the Postgraduate Institute for Medicine and ViralEd. It is not a session created by or presented at IDWeek 2020 and it is not sanctioned by the organizers of IDWeek 2020.
**This component is produced by the Annenberg Center for Health Sciences at Eisenhower and ViralEd, Inc. in collaboration with Postgraduate Institute for Medicine and supported by an independent educational grant from Janssen Therapeutics, Division of Janssen Products LP.
This activity has been designed to meet the educational needs of physicians, physician assistants, advanced practice nurses and other health care professionals involved in the care of patients with HIV infection.
After completing this activity, the participant should be better able to:
Release Date: November 4, 2020
Expiration Date: November 4, 2021
Estimated time to complete the program: 30 minutes per module
Media: Internet
Helena Kwakwa, MD, MPH
Director HIV Clinical Services
Philadelphia Department of Public Health
Ambulatory Health Services
Philadelphia, Pennsylvania
Ian Frank, MD
Professor of Medicine
Director, Clinical Therapeutics Program
Penn Center for AIDS Research
Perelman School of Medicine at the University of Pennsylvania
Philadelphia, Pennsylvania
Graeme Moyle, MD, MB, BS
Associate Director of HIV Research
Chelsea & Westminster Hospital
London, United Kingdom
Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
Renslow Sherer, MD
Professor of Medicine
Section of Infectious Diseases and Global Health
University of Chicago
Chicago, Illinois
 |
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and ViralEd, Inc. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. |
Clinical Cases in Prevention:
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Clinical Cases in COVID-19 and HIV:
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Clinical Cases in HIV Treatment and Management:
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Clinical Cases in Adverse Events and Co-morbidities:
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financialrelationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of these CME activities:
Ian Frank, MD
Graeme Moyle, MD
Helena Kwakwa, MD
Paul Sax, MD
Renslow Sherer, MD
The PIM and ViralEd planners and managers have nothing to disclose.
If you wish to receive acknowledgment for completing this activity, please complete the evaluation on www.cmeuniversity.com. On the navigation menu, click on “Find Post-test/Evaluation by Course” and search by course ID 15946. Upon registering and completing the activity evaluation, your certificate will be made available immediately.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and donot necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
This program requires a modern web browser (Internet Explorer 7+, Mozilla Firefox, Apple Safari, Google Chrome). Certain educational activities may require additional software to view multimedia, presentation, or printable version of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player and Real Networks Real One Player.
This activity is supported by an independent educational grant from Merck & Co., Inc.
This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.
* Greenwich Mean Time
